Symbol="EVOK"
AssetType="Common Stock"
Name="Evoke Pharma Inc"
Description="Evoke Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of drugs for the treatment of gastroenterological diseases and disorders. The company is headquartered in Solana Beach, California."
CIK="1403708"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="420 STEVENS AVENUE, SUITE 370, SOLANA BEACH, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="5282000"
EBITDA="None"
PERatio="None"
PEGRatio="-0.1"
BookValue="0.636"
DividendPerShare="0"
DividendYield="0"
EPS="-2.42"
RevenuePerShareTTM="0.88"
ProfitMargin="-2.859"
OperatingMarginTTM="-2.72"
ReturnOnAssetsTTM="-0.517"
ReturnOnEquityTTM="-4.085"
RevenueTTM="2900700"
GrossProfitTTM="2138300"
DilutedEPSTTM="-2.42"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.937"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.048"
PriceToBookRatio="1.033"
EVToRevenue="0.0648"
EVToEBITDA="0.195"
Beta="0.332"
num_52WeekHigh="5.96"
num_52WeekLow="1.372"
num_50DayMovingAverage="1.653"
num_200DayMovingAverage="2.247"
SharesOutstanding="3343100"
DividendDate="None"
ExDividendDate="None"
symbol="EVOK"
open="1.57"
high="1.60"
low="1.53"
price="1.53"
volume="15415.00"
latest_trading_day="2023-08-04"
previous_close="1.58"
change="-0.05"
change_percent="-3.1646%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="90"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="10"
Volume_recent_avg="23266"
Change_recent_avg="-0.03"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-1.23"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="10"
Aroon_momentum_negative="90"
image_negative_thumbnail_id_1="1131"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0164.jpeg"
image_negative_thumbnail_id_2="1099"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0132.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="531"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0068.jpeg"
image_positive_thumbnail_id_1="1008"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0170.jpeg"
image_positive_thumbnail_id_2="653"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0055.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
